The four patents-in-suit claim chemical compounds used to fight insomnia, methods for improving sleep by administering the compounds, and methods of inducing tranquilizing or hypnotic effects from the compounds, according to court documents.

FORBES: Wockhardt Fails To Nix Sepracor's Lunesta Patents